- Home
- BA vs BMY Comparison
BA vs BMY Comparison
Compare BA & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BA
- BMY
- Stock Information
- Founded
- BA 1916
- BMY 1887
- Country
- BA United States
- BMY United States
- Employees
- BA N/A
- BMY N/A
- Industry
- BA Aerospace
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- BA Industrials
- BMY Health Care
- Exchange
- BA Nasdaq
- BMY Nasdaq
- Market Cap
- BA 95.5B
- BMY 110.2B
- IPO Year
- BA N/A
- BMY N/A
- Fundamental
- Price
- BA $146.11
- BMY $57.89
- Analyst Decision
- BA Buy
- BMY Hold
- Analyst Count
- BA 22
- BMY 14
- Target Price
- BA $196.05
- BMY $53.92
- AVG Volume (30 Days)
- BA 20.0M
- BMY 12.1M
- Earning Date
- BA 10-23-2024
- BMY 10-31-2024
- Dividend Yield
- BA N/A
- BMY 4.12%
- EPS Growth
- BA N/A
- BMY N/A
- EPS
- BA N/A
- BMY N/A
- Revenue
- BA $73,293,000,000.00
- BMY $47,435,000,000.00
- Revenue This Year
- BA N/A
- BMY $6.54
- Revenue Next Year
- BA $25.74
- BMY N/A
- P/E Ratio
- BA N/A
- BMY N/A
- Revenue Growth
- BA N/A
- BMY 5.56
- 52 Week Low
- BA $137.03
- BMY $39.35
- 52 Week High
- BA $267.54
- BMY $61.08
- Technical
- Relative Strength Index (RSI)
- BA 45.51
- BMY 59.60
- Support Level
- BA $137.03
- BMY $55.82
- Resistance Level
- BA $157.66
- BMY $59.73
- Average True Range (ATR)
- BA 4.88
- BMY 1.57
- MACD
- BA -0.26
- BMY 0.07
- Stochastic Oscillator
- BA 44.01
- BMY 55.06
About BA Boeing Company (The)
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with Lockheed, Northrop, and several other firms to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.